Concept information
Preferred term
Calcium Dobesilate
Type
-
mesh:Descriptor
Definition
- A drug used to reduce hemorrhage in diabetic retinopathy.
Broader concept
Entry terms
- 20123-80-2 (Calcium Dobesilate)
- 20676-50-0 (mono-NH4+ salt)
- 21799-87-1 (mono-K salt)
- 5921X1560Q
- 86928-25-8 (Ca salt (1:1))
- Benzenesulfonic acid, 2,5-dihydroxy-, calcium salt (2:1)
- Dobesilate Calcium
Allowable Qualifier(s)
- administration & dosage (Qualifier)
- adverse effects (Qualifier)
- agonists (Qualifier)
- analogs & derivatives (Qualifier)
- analysis (Qualifier)
- antagonists & inhibitors (Qualifier)
- blood (Qualifier)
- cerebrospinal fluid (Qualifier)
- chemical synthesis (Qualifier)
- chemistry (Qualifier)
- classification (Qualifier)
- economics (Qualifier)
- history (Qualifier)
- immunology (Qualifier)
- isolation & purification (Qualifier)
- metabolism (Qualifier)
- pharmacokinetics (Qualifier)
- pharmacology (Qualifier)
- poisoning (Qualifier)
- radiation effects (Qualifier)
- standards (Qualifier)
- supply & distribution (Qualifier)
- therapeutic use (Qualifier)
- toxicity (Qualifier)
- urine (Qualifier)
Pharmacological Action(s)
In other languages
-
French
-
20123-80-2 (Calcium Dobesilate)
-
20676-50-0 (mono-NH4+ salt)
-
21799-87-1 (mono-K salt)
-
5921X1560Q
-
86928-25-8 (Ca salt (1:1))
-
Benzenesulfonic acid, 2,5-dihydroxy-, calcium salt (2:1)
-
Dobésilate calcique
URI
http://data.loterre.fr/ark:/67375/JVR-LFVPNCZV-3
{{label}}
{{#each values }} {{! loop through ConceptPropertyValue objects }}
{{#if prefLabel }}
{{/if}}
{{/each}}
{{#if notation }}{{ notation }} {{/if}}{{ prefLabel }}
{{#ifDifferentLabelLang lang }} ({{ lang }}){{/ifDifferentLabelLang}}
{{#if vocabName }}
{{ vocabName }}
{{/if}}